Yahoo Finance

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over ...

WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 ...
Nasdaq

Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes

Teleflex’s TFX escalating operating expenses are putting immense pressure on the bottom line. Tough competition and pricing pressure also weigh on the stock. The stock currently carries a Zacks Rank ...
Nasdaq

Teleflex Incorporated Reports Positive Clinical Data for UroLift™ System at AUA 2025, Highlighting Improved Patient Satisfaction and Outcomes for BPH Treatment

Teleflex Incorporated presented new clinical data at the 2025 American Urological Association Annual Meeting, highlighting the UroLift™ System as a leading minimally invasive treatment for benign ...